PNTG
Pennant Group Inc

185
Loading...
Loading...
News
all
press releases
The Pennant Group (PNTG) is an Incredible Growth Stock: 3 Reasons Why
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·15d ago
News Placeholder
More News
News Placeholder
Wall Street Analysts Predict a 39.94% Upside in The Pennant Group (PNTG): Here's What You Should Know
The consensus price target hints at a 39.9% upside potential for The Pennant Group (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·16d ago
News Placeholder
3 Reasons Growth Investors Will Love The Pennant Group (PNTG)
The Pennant Group (PNTG) could produce exceptional returns because of its solid growth attributes.
Zacks·1mo ago
News Placeholder
How Much Upside is Left in The Pennant Group (PNTG)? Wall Street Analysts Think 31.17%
The mean of analysts' price targets for The Pennant Group (PNTG) points to a 31.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·1mo ago
News Placeholder
The Pennant Group (PNTG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for The Pennant Group (PNTG) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·1mo ago
News Placeholder
The Pennant Group, Inc. (PNTG) Q2 Earnings and Revenues Surpass Estimates
The Pennant Group (PNTG) delivered earnings and revenue surprises of +3.85% and +3.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of +9.26% and +1.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, DaVita and The Pennant
DGX, EHC, DVA, and PNTG are riding the outpatient healthcare shift as tech, AI, and aging demand reshape the care landscape.
Zacks·3mo ago
News Placeholder
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
Zacks·3mo ago
News Placeholder
Encompass Health to Expand Florida Presence With New 50-bed Facility
Zacks·4mo ago

Latest PNTG News

View

Advertisement. Remove ads.

Advertisement. Remove ads.